In contrast, elevated ARHGEF3 expression is a crucial contributor to the pathogenesis of nasopharyngeal carcinoma (NPC) by inhibiting cell apoptosis and potentially used as a novel marker for prognosis and an effective target for treatment [38]. The gene discussed is ARHGEF3; the disease is nasopharyngeal carcinoma.